Skip to main content
SpringerLink
Log in

Hepatobiliary Cancer

  • Book
  • © 1994

Overview

Editors:
  1. Paul H. Sugarbaker

    1. The Cancer Institute, Washington Hospital Center, USA

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

Part of the book series: Cancer Treatment and Research (CTAR, volume 69)

This is a preview of subscription content, log in via an institution to check access.

Access this book

Log in via an institution
eBook USD 259.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 329.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book USD 329.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (27 chapters)

  1. Front Matter

    Pages i-xviii
    Download chapter PDF

  2. Inefficiency of metastasis from colorectal carcinomas

    • Leonard Weiss
    Pages 1-11

  3. Cytoreductive approach to treatment of multiple liver metastases

    • Paul H. Sugarbaker, Mark A. Steves
    Pages 13-20

  4. Hepatoma registry of the western world

    • Jane I. Tsao, Horacio J. Asbun, Kevin S. Hughes, Sabas Abaubara, David A. August, Arturo Azurin et al.
    Pages 21-31

  5. Resection of hepatic metastases from colorectal carcinoma

    • Horacio J. Asbun, Jane I. Tsao, Kevin S. Hughes
    Pages 33-41

  6. Surgical management of hepatic metastases from large bowel cancer

    • Bernard Nordlinger, Pierre Balladur
    Pages 43-51

  7. Repeat resections of primary hepatic malignancies

    • Bernard Nordlinger, Philippe Wind
    Pages 53-56

  8. Repeat resections for recurrent colorectal liver metastases

    • Bernard Nordlinger, J.-C. Vaillant
    Pages 57-61

  9. Liver transplantation as an option for primary malignancy

    • Henri Bismuth, Laurence Chiche
    Pages 63-73

  10. Surgical treatment of cholangiocarcinoma

    • Leslie H. Blumgart, Steven C. Stain
    Pages 75-96

  11. Treatment of gallbladder cancer

    • Harold J. Wanebo, Michael P. Vezeridis
    Pages 97-109

  12. Use of clamps in hepatobiliary surgery

    • Kenneth P. Ramming
    Pages 111-119

  13. Chemotherapy after hepatic resection of colorectal metastases

    • M. Margaret Kemeny
    Pages 121-128

  14. Radiological evaluation of metastases to the liver: The Emory Experience

    • Rendon C. Nelson
    Pages 129-146

  15. Hepatic vascular exclusion for hepatic resection

    • James A. Knol, Frederick E. Eckhauser
    Pages 147-155

  16. Radiologic evaluation and treatment of gallbladder and biliary tree carcinoma

    • Ann Archer, Keith Horton
    Pages 157-183

  17. Repeat liver resections from colorectal metastasis

    • Vicente Fernández-Trigo, Falah Shamsa, Joaquin Aldrete, Roland Andersson, Jean-Pierre Arnaud, Roberto Bergamaschi et al.
    Pages 185-196

  18. Intraoperative ultrasound and liver tumors

    • Steven T. Brower, Myron Schwartz, Charles Miller
    Pages 197-220

  19. Parenchymal dissection techniques

    • W. John B. Hodgson
    Pages 221-230

  20. Surgical resection and transplantation for hepatocellular carcinoma

    • Bernard Langer, Paul D. Greig, Bryce R. Taylor
    Pages 231-240
Back to top

Keywords

About this book

When one deals with cancer, the hepatobiliary malignancies present a chal­ lenge to the oncologists that can be characterized as a series of unsolved clinical and biological dilemmas. Liver metastases from colorectal and other gastrointestinal malignancies, hepatocellular carcinoma, cholangiocar­ cinoma, and gall bladder cancer present an array of problems but have two features in common. These are high morbidity and mortality with an overall poor result from treatment. Why is it that hepatobiliary cancer carries with it such a dismal prognosis? First of all, these diseases present, for the most part, in an advanced state. To this point in time the oncologist has had no help from early diagnosis or screening. Only the occasional patient followed by ultrasound or a tumor marker has the disease diagnosed in an asymptomatic state. By the time these diseases become symptomatic, curative treatment options have usually disappeared. Evolution has placed the liver in a protected position in order to avoid injury to the soft parenchyma. As with many other internal organs, the nerve supply is extremely limited. These two anatomic features result in a great lack of early warning signs of cancer.

Editors and Affiliations

  • The Cancer Institute, Washington Hospital Center, USA

    Paul H. Sugarbaker

Bibliographic Information

  • Book Title: Hepatobiliary Cancer

  • Editors: Paul H. Sugarbaker

  • Series Title: Cancer Treatment and Research

  • DOI: https://doi.org/10.1007/978-1-4615-2604-9

  • Publisher: Springer New York, NY

  • eBook Packages: Springer Book Archive

  • Copyright Information: Springer Science+Business Media Dordrecht 1994

  • Hardcover ISBN: 978-0-7923-2501-7Published: 31 May 1994

  • Softcover ISBN: 978-1-4613-6115-2Published: 13 March 2013

  • eBook ISBN: 978-1-4615-2604-9Published: 09 March 2013

  • Series ISSN: 0927-3042

  • Series E-ISSN: 2509-8497

  • Edition Number: 1

  • Number of Pages: XVIII, 326

  • Number of Illustrations: 99 b/w illustrations

  • Topics: Oncology, Abdominal Surgery

Publish with us

Policies and ethics

Back to top

Search

Navigation